ArticlePDF Available

Abstract and Figures

Background: Moringa peregrina (M. peregrina) is an edible, drought-resistant tree that is native to semi-arid countries. It is used as a painkiller in folk medicine. Aims: To study the antinociceptive effects of the leaf extract of M. peregrina in mice. Study Design: Animal experimentation. Methods: We employed thermal (hot plate and tail-immersion tests) and chemical (writhing and formalin tests) pain models in male BALB/c mice (eight animals per group) to investigate the mechanisms involved in the antinociceptive actions of M. peregrina. Additionally, we identified the chemical constituents present in the extract of M. peregrina by using liquid chromatography-mass spectrometry analysis, and predicted the possible active constituents that interact with the receptor based on molecular docking simulations. Results: In the writhing test, 200 mg/kg of M. peregrina extract restricted abdominal cramps by up to 55.97% (p
Content may be subject to copyright.
Balkan Med J 2020;37:189-95 Original Article 189
Antinociceptive Action of Moringa peregrina is Mediated by an
Interaction with α2-Adrenergic Receptor
1Department of Biological Sciences, Jordan University School of Science, Amman, Jordan
2Department of Pharmaceutical Sciences, Al-Ahliyya Amman University School of Pharmacy, Amman, Jordan
3Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Al-Ahliyya Amman University, Amman, Jordan
Sahar M. Jaffal1, Belal O. Al-Najjar2, Manal A. Abbas3, Sawsan A. Oran1
Background: Moringa peregrina (M. peregrina) is an edible,
drought-resistant tree that is native to semi-arid countries. It is used as
a painkiller in folk medicine.
Aims: To study the antinociceptive effects of the leaf extract of
M. peregrina in mice.
Study Design: Animal experimentation.
Methods: We employed thermal (hot plate and tail-immersion tests)
and chemical (writhing and formalin tests) pain models in male
BALB/c mice (eight animals per group) to investigate the mechanisms
involved in the antinociceptive actions of M. peregrina. Additionally,
we identified the chemical constituents present in the extract of
M. peregrina by using liquid chromatography-mass spectrometry
analysis, and predicted the possible active constituents that interact
with the receptor based on molecular docking simulations.
Results: In the writhing test, 200 mg/kg of M. peregrina extract
restricted abdominal cramps by up to 55.97% (p<0.001). Further,
it reduced the time of paw-licking in the early and late phases of
formalin test by up to 56.8% and 65.5%, respectively, as compared to
the percentage inhibitions of 50.5% and 48.4% produced by 30 mg/kg
diclofenac sodium in the early and late phases, respectively (p<0.05).
This effect was abrogated by yohimbine (1 mg/kg, intraperitoneally),
but not by methysergide (5 mg/kg, intraperitoneally), in the late phase
only, which indicates that the action of M. peregrina in formalin
test is not mediated by 5-HT2 serotonin receptors, but rather via α2-
adrenergic receptors. In the hot plate test, but not on tail-immersion
test, the high dose (400 mg/kg) of the extract increased the latency
time after 30 minutes of its administration. Yohimbine antagonized
the action of M. peregrina in the hot plate test. Based on LC-MS
analysis, the major constituents found in M. peregrina methanolic
extract were chrysoeriol 7-O-diglucoside, lupeol acetate, quercetin,
and rutin. Depending on the molecular docking results, the activity
of M. peregrina extract could be due to the binding of chrysoeriol
7-O-diglucoside, quercetin, and rutin to the α2-adrenergic receptor.
Conclusion: Interaction with the α2-adrenergic receptor serves as a
possible mechanism of the M. peregrina analgesic effect.
Keywords: Adrenergic alpha-2 receptor antagonists, analgesics,
molecular docking, Moringa peregrina
Moringa (Moringaceae) is a genus that comprises 13 species of trees
and shrubs growing in the tropical and sub-tropical regions of our
world (1). Various civilizations, such as Greek, Indian, and Egyptian,
have utilized Moringa for many millennia. Moringa (mainly its
leaves and fruits) has always been an integral part of people’s diet.
Additionally, Moringa leaves were fed to the ancient Mauryan
warriors of India to provide them with energy and relieve their pain
(2). Moringa peregrina (M. peregrina) is a drought-resistant tree that
grows in the dry or semi-arid countries located near the Red Sea such
as Somalia, Syria, Palestine, and Yemen (3). The tree is known for
its fast growth and can reach up to 3-10 meters in height after ten
months of its cultivation (4). The leaves of M. peregrina are obovate,
alternate, deciduous, and about 30-40 cm in length (2). Almost all
parts of this plant are consumed by humans as a vegetable due to its
taste, flavor, and nutritional value. The leaves of M. peregrina are
great sources of proteins, vital elements (Ca
+2
, Mg
+2
, K
+1
and Fe
+2
),
essential amino acids, and vitamins such as vitamin A, C, and E (5,6).
M. peregrina is considerably used by people of various cultures
in traditional healing practices during childbirth and for treating
multiple disorders, such as malaria, fever, diabetes, abdominal pain,
asthma, headache, constipation, muscle pain, hypertension, burns
(7,8). Pharmacological studies have reported that M. peregrina
has antimicrobial (9), in vitro antioxidant (8), anticancer (10), and
antispasmodic properties (7) as well as immunomodulatory activities
(both ex vivo and in vivo) (3). In rats, M. peregrina has demonstrated
anti-inflammatory (11), antiulcer (12), antihyperglycemic (13),
antihyperlipidemic (14), antihypertensive effects (15), and memory-
enhancing activities (16).
Address for Correspondence: Manal A. Abbas, Department of Biological Sciences, Jordan University School of Science, Amman, Jordan
Phone: +962 0777 405887 e-mail: m.abbas@ammanu.edu.jo ORCID: orcid.org/0000-0002-8962-1879
Received: 04 November 2019 Accepted: 02 March 2020 • DOI: 10.4274/balkanmedj.galenos.2020.2019.11.14
Available at www.balkanmedicaljournal.org
Cite this article as:
Jaffal SM, Al-Najjar BO, Abbas MA, Oran SA. Antinociceptive Action of Moringa peregrina is Mediated by an Interaction with α2-Adrenergic Receptor.
Balkan Med J 2020;37:189-95
©Copyright 2020 by Trakya University Faculty of Medicine / The Balkan Medical Journal published by Galenos Publishing House.
Despite the use of M. peregrina in folk medicine as a painkiller
(4), there is a paucity of detailed studies determining the analgesic
effects of this plant. Previous work on M. peregrina includes only
a preliminary investigation that employed writhing and hot plate
tests (12). The purpose of this investigative study is to examine
the effects of M. peregrina on the early and late phases of formalin
test. Additionally, we performed tail-immersion test to study
the effects of M. peregrina at the spinal level. Furthermore, we
studied the mechanism by which M. peregrina exerts its action.
MATERIALS AND METHODS
Drugs
Diclofenac sodium was obtained from Novartis, Switzerland,
whereas methysergide was obtained from Sigma-Aldrich, USA.
Yohimbine was purchased from Tocris Bioscience (UK). All the
drugs were freshly prepared in a sterile normal saline solution and
administered intraperitoneally (i.p).
Collection of plant material
The leaves of M. peregrina were collected in June 2012 from Wadi
Bin-Hammad Valley (Karak, south of Jordan). Professor Sawsan
Oran, plant taxonomist at the University of Jordan, authenticated
the leaves.
Preparation of plant extract
The dried leaves of M. peregrina were extracted by maceration
in 96% methanol (Scharlau Chemie, Spain). Rotary evaporator
was used to evaporate methanol under reduced pressure and at a
temperature not more than 45oC. The extract was stored at -20°C,
and it was freshly prepared, before its use, by dissolving it in the
sterile normal saline solution.
Experimental animals
All employed procedures in this study complied with the
guidelines of the International Association for the Study of Pain
(17) and were approved by the ethical committee at Al-Ahliyya
Amman University (ethical approval no. AAU-2/4/2018). Male
BALB/c mice (weight: 20-25 g) were kept at standard laboratory
conditions (at 23±2
o
C in both dark and light environments
consecutively). Food and water were provided ad libitum.
The animals were allowed to acclimatize to the experimental
laboratory conditions for 120 minutes before the commencement
of experiments.
Pretreatment of animals
In all the experiments, animals were pretreated i.p with 10 mL/
kg vehicle (sterile normal saline solution, control) along with 200
mg/kg or 400 mg/kg M. peregrina methanolic extract 30 minutes
before the commencement of the experiments. Diclofenac sodium
(30 mg/kg) was used as a standard drug similar to the research
of Jaffal and Abbas (18). Methysergide (5 mg/kg) or yohimbine
(1 mg/kg) was injected 15 minutes before the administration of
a fixed dose of M. peregrina extract (200 mg/kg or 400 mg/kg).
The choice of doses of antagonists was based on the previously
published studies (19,20).
Writhing test
Writhing test was conducted, as per Koster method (21), via
the administration of acetic acid solution (1%, 10 mL/kg) i.p in
the animals 30 minutes after receiving the vehicle solution, M.
peregrina extract (200 mg/kg or 400 mg/kg), or diclofenac sodium.
Each group consisted of eight animals (mice). After 10 minutes
of acetic acid administration, the number of writhes was counted
for 20 minutes. A writhe is considered as a contraction of the
abdominal muscles accompanied by the elongation of the body and
extension of the forelimbs. The percentage inhibition of abdominal
cramps was calculated by using the following formula:
% inhibition = Average number of writhes in control - Average
number of writhes in treated animals × 100%
Average number of writhes in control.
Paw-licking test
Paw-licking test was performed after the intraplantar administration
of 2.5% formalin (20 µL) to the left hind paw of the mouse. The total
time spent in licking the injected paw, lifting the leg, or exhibiting
a flinching behavior were recorded in the first 5 minutes after the
administration of formalin (early phase) and during the late phase
(25-30 minutes after injection). The percentage inhibition was
calculated according to the following formula:
% inhibition= Average time of licking in control - average time of
licking in treated animals × 100%
Average time of licking in control
Hot plate test
The hot plate test was used to determine latencies in pain reaction.
Mice reactions were assessed by individually placing the animals
into a transparent container on a hot plate at 55±1oC. Each mouse
underwent this procedure only once. The time between the animal’s
placement and first jump was recorded as a measure for the latency
of pain reaction. A cut-off time of 60 seconds was determined to
avoid tissue damage.
Tail-immersion test
Tail-immersion test was performed by dipping the tail in water at
55±1oC. The time starting from immersing the tail in water till the
appearance of the first flick was calculated. A cut-off time of 10
seconds was determined.
Liquid chromatography-mass spectrometry (LC-MS)
LC-MS separation was performed in the mobile phase. This phase
have solvents A and B in gradient, in which A contained 0.1%
(v/v) formic acid in water and B had 0.1% (v/v) formic acid in
acetonitrile. Agilent ZORBAX Eclipse XDB-C18 column (2.1×150
mm ×3.5 μm) was used in this procedure. The oven was set at 25
̊C, and the volume of injection was 1 μL containing 18 mg/mL in
methanol. We used Shimadzu LC-MS 8030 with electrospray ion
mass spectrometer (ESI-MS) to monitor the eluent under positive
ion mode. Then, we scanned it from 100 to 1,000 mass/number of
ions (m/z). ESI was performed by using skimmer 65 V and at a
fragmentor voltage of 125 V. Highly pure (99.99%) nitrogen was
used as drying gas at 10 L/min flow rate, capillary temperature
at 350 ̊C, and nebulizer at 45 psi. The sample was injected to the
190
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina
mass detector by using the LC-30AD pump, Shimadzu CBM-
20A system controller, cooler, and CTO-30 column oven with the
SIL-30AC autosampler. The results were validated by running the
authentic standard compounds and referring to the literature as in
the research of (16).
Protein preparation and homology modeling
The homology model for α2-adrenergic receptor was developed
from the SWISS-MODEL server (22). Other software included in
this study were Discovery Studio Visualizer 4.0 (Accelrys Software
Inc, San Diego; http://www.accelrys.com), ACD/ChemSketch,
(www.acdlabs.com), and AutoDock4 (23).
The protein sequence of α2-adrenergic receptor was selected from
the universal protein source under the code no. P08913. The
homology model of the protein was built at the SWISS-MODEL
web server program. Initially, BLAST (24) was used to search for
the target sequences against the primary amino acid sequence.
Thereafter, the quality of the template was predicted from the
target-template alignment features. Further, the best-quality
templates were chosen for building the model.
Molecular Docking
ACD/ChemSketch software was used to construct the chemical
structures of major compounds in M. peregrina extract. These
compounds were chrysoeriol 7-O-diglucoside, lupeol acetate,
quercetin, and rutin. The compounds were drawn and saved as MOL
files by ChemSketch software and then converted to PDB files.
Ligand files in the PDB format were prepared by AutoDockTools.
Each compound was opened separately, charges were added, and all
the hydrogen atoms were merged. Molecular docking simulations
of the compounds were performed by utilizing AutoDock 4.2.
Kollman and Gasteiger charges were added to both proteins and
plant compounds, respectively. A set of grid maps were created by
using AutoGrid 4 (The Scripps Research Institute, San Diego, CA,
USA). Then, a grid box was utilized to select the area of the protein
structure to be mapped. The box size was set to 22.5, 22.5, and 22.5
Å (x, y, and z, respectively). Energy optimization and minimization
was conducted by applying Lamarckian genetic algorithm in the
docking simulation (16).
Statistical analysis
All data of this study passed the normality test (Shapiro-Wilk test).
Brown-Forsythe and Welch One-Way analysis of variance tests for
parametric analysis were used to examine the statistical difference
between the groups. Version 6 of GraphPad Prism was chosen to
perform the statistical analysis of this study.
RESULTS
In the writhing test, 200 mg/kg and 400 mg/kg of M. peregrina
extract inhibited abdominal cramps by up to 55.97% and
88.00%, respectively, as compared to inhibition percentage of
47.69% produced by 30 mg/kg of diclofenac sodium. Yohimbine
antagonized the action of M. peregrina in the writhing test
(Table 1). Additionally, the methanolic extract of M. peregrina
reduced the time of paw-licking in the early and late phases of
formalin test. high (400 mg/kg) and low (200 mg/kg) doses of
M. peregrina extract exhibited inhibition percentages of 59.6%
and 56.8%, respectively, whereas 30 mg/kg diclofenac sodium
produced an inhibition percentage of only 50.5% in the early
phase of formalin test (Figure 1A). High (400 mg/kg) and low
(200 mg/kg) doses of M. peregrina extract exhibited inhibition
percentages of 50.1% and 65.5%, respectively, as compared to an
inhibition percentage of 48.4% achieved by 30 mg/kg diclofenac
sodium in the late phase of formalin test (Figure 1B). This effect
(in late phase only) was abrogated by yohimbine, but not by
methysergide.
In the hot plate, but not tail-immersion test, a high dose of M.
peregrina (400 mg/kg) extract increased the latency time after 30
minutes of its administration. Yohimbine antagonized the action
of M. peregrina in the hot plate test (Table 2). By using LC-MS,
18 compounds were detected in the extract (Table 3). Chrysoeriol
7-O-diglucoside, lupeol acetate, quercetin, and rutin were the
major compounds present in this extract.
SWISS-MODEL had generated around 531 templates, of which the
top 50 filtered templates can be found in the supplementary material
(Table S1). The homology model of α
2
-adrenergic receptor having
a resolution of 1.96 Å was validated by using the Ramachandran
plot (Figure S1 in supplementary materials). Quality estimate of the
homology model is presented in Figure S2 while predicted local
similarity to target for the homology model is shown in Figure S3 in
supplementary material. Figure 2 shows all the successfully docked
plant constituents against the α
2
-adrenergic receptor model, and
Table 4 shows the results of lowest binding energies .
The docking results showed a higher binding affinity for the
compounds, namely chrysoeriol 7-O-diglucoside, quercetin,
and rutin, with a low affinity for lupeol acetate. Further
investigation of these compounds in the binding site have
revealed that chrysoeriol 7-O-diglucoside, quercetin, and
rutin participate in the hydrogen bond interactions as well as
hydrophobic interactions within the binding site, whereas
lupeol acetate participates only in the hydrophobic interactions
(Figure 3).
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina 191
TABLE 1. Writhing test results
Control
(normal saline)
M. peregrina
(200 mg/kg)
Yohimbine (1 mg/
kg) and M. peregrina
(200 mg/kg)
M. peregrina
(400 mg/kg)
Yohimbine (1 mg/kg)
and M. peregrina
(400 mg/kg)
Diclofenac sodium
(30 mg/kg)
No of writhing 49.00±3.16 21.57±6.65* 54.80±7.79#5.88±4.22* 18.25±8.88£25.63±7.78*
% inhibition - 55.97% - 88.00% - 47.69%
P value - p<0.0001 p<0.0001 p<0.0001 p<0.05 p<0.0001
n=8 values are mean ± standard deviation of the mean, *Significantly different from control, #Significantly different from M. peregrina (200 mg/kg), £Significantly different from M.
peregrina (400 mg/kg)
192
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina
TABLE 2. Results of thermal antinociceptive tests: hot plate and tail flick tests
Control
(normal saline)
M. peregrina
(200 mg/kg)
M. peregrina
(400 mg/kg)
Yohimbine (1 mg/kg) and
M. peregrina
(400 mg/kg)
Diclofenac sodium
(70 mg/kg)
Latency time in hot plate test (sec.) 9.23±1.63 9.46±1.85 30.87±2.21*
p<0.0001
22.03±5.35#
p<0.0001
22.84±2.99*
p<0.0001
Latency time in tail flick test (sec.) 2.92±0.53 2.70±0.60 2.34±0.60 - 4.49*±0.63
p<0.001
n=14 Values are mean ± standard deviation of the mean, *Significantly different from control, #Significantly different from M. peregrina (400 mg/kg)
FIG. 1. a, b. Results of paw-licking test (formalin test). (a) Early phase
(0-5 minutes after injection) (b) Late phase (25-30 minutes after
injection).
*Signicant difference from the control (p<0.05), **P<0.05 signicantly
different from M. peregrina (200 mg/kg)
FIG. 2. Solid ribbon representation of α2-adrenergic receptor docked
with the major compounds in M. peregrina extract, namely chrysoeriol
7-O-diglucoside, lupeol acetate, quercetin, and rutin, in the active site
of the receptor.
TABLE 3. Chemical constituents of M. peregrina as detected by liquid
chromatography-mass spectrometry
Compound %
1 Apigenin 0.88
2 Amyrin 10.1
3 Beta-sitosterol-3-d-glucoside 7.1
4 2-Butyl isothiocyanate 1.8
5 Chrysoeriol 7-O-diglucoside 16.3
6 5,5-Dimethyl-3-phenyl-1,3-oxazolidine-2-thione 3.3
7 Lupeol acetate 15.7
8 Methyl Glucosinolate 1.8
9 2-Methylpropyl isothiocyanate 3.1
10 Neochlorogenic acid 0.63
11 Niazirin 0.68
12 Niazirinin 1.8
13 2-Propyl isothiocyanate 2.2
14 Quercetin 13.3
15 Rhamnetin 1.05
16 4(a-L Rhamnosyloxy) benzyl isothiocyanate 0.97
17 Rutin 11.4
18 Sitosterol 6.3
DISCUSSION
In our study, M. peregrina exhibited marked analgesic properties
induced by acetic acid in the writhing test. The percentage inhibition
produced by 200 mg/kg and 400 mg/kg doses were 55.97% and
88%, resprctively. Similar findings were obtained by Elbatran et
al. (12) in which 113.4 mg/kg of M. peregrina decreased acetic
acid-induced abdominal cramps by 70.7% in mice. Additionally, at
the doses of 100 and 200 mg/kg, M. oleifera extract significantly
decreased writhes (25). This effect was not reversed by naloxone,
thereby indicating a peripheral non-opioid mechanism of action
(26). Bhattacharya et al. (27) also found that M. oleifera extract
exhibited analgesic activity at 100, 200, and 400 mg/kg in acetic
acid-induced abdominal cramps in the writhing test, further
showing percentage inhibitions of 32.21%, 59.71%, and 78.61%
of writhes, respectively, as compared with the control group (27).
M. peregrina leaf extract demonstrated noticeable antinociception
in the early and late phases of the formalin test. The administration
of formalin causes three distinct periods with high licking
behavior: an early phase lasting the first 5 minutes, and a late
phase in the last 5 minutes after the injection. The early phase
(neurogenic pain) is due to the direct activation of the primary
afferent fibers. The late phase is known as inflammatory pain,
thereby representing the effect in the primary afferents and central
sensitization of spinal cord circuits secondary to the events that
occurred during Phase I (28). The lowest dose of M. peregrina
(200 mg/kg) was more active in the late phase than in the early
phase and was more active than the higher dose (400 mg/kg). This
can be explained by the non-specific effect of compounds in a
higher dose with receptors that can block the interaction of active
compounds with the receptor involved in the antinociceptive
action. As per our knowledge, this study is the first one to report
on the activity of M. peregrina in the formalin test. Similarly, M.
oleifera leaves exhibited antinociceptive activity in the late phase
(25,26). Both polar and non-polar extracts of M. oleifera leaves
were effective in both phases of formalin test. Due to the presence
of central and peripheral actions of non-polar active compounds,
the hexane extract was more effective than the ethanolic extract
(29).
In the hot plate test, a high dose of M. peregrina (400 mg/kg) extract
increased the latency time after 30 minutes of its administration.
Similar results were reported by Elbatran et al. (12). In search
for the mechanism of antinociceptive action of M. peregrine, the
antagonists for adrenergic and 5-hydroxytryptamine type 2 (5-
HT2) serotonergic receptors were used in this study since previous
studies suggested that the closely related species of M. oleifera
interact with both dopaminergic and 5-HT2 serotonergic receptors
(30). This study showed that yohimbine antagonized the action of
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina 193
FIG. 3. a-d. Stick representation of a. chrysoeriol 7-O-diglucoside, b.
lupeol acetate, c. rutin, and d. quercetin in the active site that forms
hydrophobic (pink dots) interactions and hydrogen bond (green dots)
with α2-adrenergic receptor.
TABLE 4. The lowest binding energies obtained from AutoDock 4.2 for plant constituents against α2-adrenergic receptor and the interacting amino acids.
Compound Lowest binding energy (kcal/mol) Interacting amino acids
Chrysoeriol 7-O-diglucoside -8.74 Asn93, Glu94, Arg187, Cys188, Asn191, Ser200, Tyr394, Arg405.
Lupeol acetate -4.01 Leu110, Val186, Cys188, Lys409.
Quercetin -7.88 Ser90, Asn93, Glu94, Asp113, Val186.
Rutin -8.67 Glu94, Asp113, Ile190, Asn191, Tyr394, Trp413, Tyr416.
M. peregrina in the hot plate test. As per our knowledge, this is the
first report that shows the involvement of α2-adrenergic receptors
in the action of M. peregrina. The related species of M. oleifera
showed significant analgesic dose-dependent activity in the hot
plate test (27). Study suggested that the effect of M. oleifera in the
hot plate test is modulated at the central antinociceptive level via
opioid receptors since the use of naloxone (5 mg/kg) reversed the
effect of extract (26).
In the tail-immersion test, M. peregrina extract had no effect on the
latency time of tail immersion after the administration of extract. In
contrast, M. oleifera produced considerable antinociceptive action
by enhancing tail-immersion latency period at 30 minutes (31). This
could be explained by the presence of different phytoconstituents
in the two species.
Both tail-immersion and hot plate tests are thermal acute pain tests.
However, tail-immersion test works at the spinal level, whereas the
hot plate test is a supraspinally controlled test (32). To the best of
our knowledge, this study is the first one to report the lack of spinal
reflexive action of M. peregrina.
Elbatran et al. (12) isolated four flavonoids from the aerial parts
of M. peregrina and found that the major flavonoids are quercetin-
3-0-rutinoside (rutin), quercetin, chrysoeriol-7-0-rhamnoside, and
6,8,3,5-tetramethoxy apigenin. These flavonoids showed both
analgesic and anti-inflammatory properties. Additionally, the
aerial sections of M. peregrina have β-sitosterol-3-O-glucoside,
β-sitosterol, α-amyrin, β-amyrin, lupeol acetate, apigenin,
6-methoxy-acacetin-8-C-β-glucoside, neochlorogenic acid,
rhamnetin, and rhamnetin-3-O-rutinoside (13). Lupeol acetate
isolated from M. peregrine has a well-documented analgesic
activity (33).
Depending on the previous results, we propose that the plant extract
will interact with α
2
-adrenergic receptor to exert its analgesic activity.
Thus, it will be useful to determine the active compounds that are
responsible for this action. Due to the absence of complete α
2
-adrenergic
receptor crystal structure, homology modeling is considered as an
attractive technique for obtaining the structure. Such technique has
proven to be an appropriate choice to obtain the useful 3D structure
of the protein (34). Furthermore, molecular docking simulations have
shown a good affinity of chrysoeriol 7-O-diglucoside, quercetin, and
rutin toward the active site of the receptor.
In conclusion, our results suggest an interaction with α2-adrenergic
receptor as a possible mechanism of analgesic action of M.
peregrina. Depending on the molecular docking results, the activity
of M. peregrina extract with α2-adrenergic receptor could be due
to the binding of chrysoeriol 7-O-diglucoside, quercetin, and rutin
compounds to the receptor.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: This work was published with the support of Al-Ahliyya
Amman University.
Supplementary: balkanmedicaljournal.org/uploads/pdf/supplementarymaterials.pdf
REFERENCES
1. Said-al Ahl HAH, Hikal WM and Mahmoud AA. Biological Activity of Moringa
peregrina , A Review. Am J Food Sci Heal 2017;3:83-7.
2. Senthilkumar A, Karuvantevida N, Rastrelli L, Kurup SS, Cheruth AJ. Traditional
Uses, Pharmacological Efficacy, and Phytochemistry of Moringa peregrina (Forssk.)
Fiori. -A Review. Front Pharmacol 2018;9:465.
3. Al-Majali IS, Al-Oran SA, Hassuneh MR, Al-Qaralleh HN, Rayyan WA, Al-Thunibat
OY, et al. Immunomodulatory effect of Moringa peregrina leaves,1 ex vivo and in
vivo study. Cent Eur J Immunol 2017;42:231-8.
4. Padayachee B and Baijnath H. An overview of the medicinal importance of
Moringaceae. J Med Plants Res 2012;6:5831-9.
5. Asghari G, Palizban A, Bakhshaei B. Quantitative analysis of the nutritional
components in leaves and seeds of the Persian Moringa peregrina (Forssk.) Fiori.
Pharmacognosy Res 2015;7:242-8.
6. Osman H and Abohassan A. Morphological and analytical characterization of Moringa
peregrina populations in western Saudi Arabia. Int J Theor Appl Sci 2012;4:174-84.
7. Sadraei H, Asghari G, Farahnaki F. Assessment of hydroalcoholic extract of seeds and
leaves of Moringa peregrina on ileum spasm. Res Pharm Sci 2015;10:252-8.
8. El-Lamey TM. Ecophysiological responses of Moringaperegrina (Forssk.) Fiori
growing naturally under different habitat conditions of Eastern Desert and Fieran
Oasis, Egypt J Agric Vet Sc 2015;8:8-21.
9. Majali I, Althunibat OY, Qaralleh HN. Antimicrobial and Immunomodulatory
activities of Moringa peregrine-Minireview. J Bas and Appl Res. 2015; 1: 55-61.
10. El Baky HA, El-Baroty GS. Characterization of Egyptian Moringa peregrine seed oil
and its bioactivities. Int J Manage Sci Bus Res 2013;2:98-108.
11. Koheil MA, Hussein MA, Othman SM, El-Haddad A. Anti-inflammatory and
antioxidant activities of Moringa peregrina seeds. Free Radical and Antioxidants
2011;1:49-61.
12. Elbatran SA, Abdel-Salam OM, Abdelshfeek KA, Nazif NM, Ismail SI, Hammouda
FM. Phytochemical and pharmacological investigations on Moringa peregrina
(Forssk) Fiori. Nat Prod Sci 2005;11:199-206.
13. El-Alfy TS, Ezzat SM, Hegazy AK, Amer AM, Kamel GM. Isolation of biologically
active constituents from Moringa peregrina (Forssk.) Fiori.(family: Moringaceae)
growing in Egypt. Pharmacogn Mag 2011;7:109-15.
14. Oyedepo T, Babarinde S, Ajayeoba T. Evaluation of anti-hyperlipidemic effect of
aqueous leaves extract of Moringa oleifera in alloxan induced diabetic rats. Int J
Biochem Res Rev 2013;3:162-70.
15. Safaeian L, Asghari G, Javanmard SH, Heidarinejad A. The effect of hydroalcoholic
extract from the leaves of Moringa peregrina (Forssk.) Fiori. on blood pressure and
oxidative status in dexamethasone-induced hypertensive rats. Adv Biomed Res
2015;4:101.
16. Alzoubi KH, Rawashdeh NQ, Khabour OF, El-Elimat T, Albataineh H, Al-Zghool
HM, et al. Evaluation of the effect of Moringa peregrina extract on learning and
memory: Role of oxidative stress. J Mol Neurosci 2017;63:355-63.
17. Zimmermann M. Ethical guidelines for investigations of experimental pain in
conscious animals. Pain 1983;16:109-10.
18. Jaffal SM, Abbas MA. Antinociceptive Action of Ononis spinosa leaf extract in
mouse pain models. Acta Pol Pharm 2019;76:299-304.
19. Rodrigues AL, Rosa JM, Gadotti VM, Goulart EC, Santos MM, Silva AV, et al.
Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4
″-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice. Pharmacol Biochem
Behav 2005;82:156-62.
20. de Lima FO, Alves V, Barbosa Filho JM, Almeida JR, Rodrigues LC, Soares MB,
et al. Antinociceptive effect of lupeol: evidence for a role of cytokines inhibition.
Phytother Res 2013;27:1557-63.
21. Koster R, editor Acetic acid for analgesic screening. Fed Proc 1959;18:418-20.
22. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al.
SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic
Acids Res 2018;46:296-303.
23. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al.
AutoDock4 and AutoDockTools4: Automated docking with selective receptor
flexibility. J Comput Chem 2009;30:2785-91.
24. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al.
BLAST+: architecture and applications. BMC Bioinformatics 2009;10:421.
25. Adedapo AA, Falayi OO, Oyagbemi AA. Evaluation of the analgesic, anti-
inflammatory, anti-oxidant, phytochemical and toxicological properties of the
methanolic leaf extract of commercially processed Moringa oleifera in some
laboratory animals. J Basic Clin Physiol Pharmacol 2015;26:491-9.
194
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina
26. Sulaiman MR, Zakaria ZA, Bujarimin AS, Somchit MN, Israf DA, Moin S. Evaluation
of moringa oleifera aqueous extract for antinociceptive and anti-inflammatory
activities in animal models. Pharm Biol 2008;46:838-45.
27. Bhattacharya A, Agrawal D, Sahu PK, Kumar S, Mishra SS, Patnaik S. Analgesic
effect of ethanolic leaf extract of Moringa oleifera on albino mice. Indian J Pain
2014;28:89-94.
28. Hassani FV, Rezaee R, Sazegara H, Hashemzaei M, Shirani K, Karimi G. Effects of
silymarin on neuropathic pain and formalin-induced nociception in mice. Iran J Basic
Med Sci 2015;18:715-20.
29. Martínez-González CL, Martínez L, Martínez-Ortiz EJ, González-Trujano ME,
Déciga-Campos M, Ventura-Martínez R, et al. Moringa oleifera, a species with
potential analgesic and anti-inflammatory activities. Biomed Pharmacother
2017;87:482-8.
30. Upadhye KP, Rangari VD, Mathur VB. Antimigraine activity study of Moringa
oleifera leaf juice. International Journal of Green Pharmacy 2012;6:204-7.
31. Bhairi RS, Rasheeduddin M, Nadithe LR. Comparative Study of Analgesic Effect of
Moringa Oleifera with Lornoxicam in Rats. J Cont Med A Dent 2015;3:44-7.
32. Singh P, Kongara K, Harding D, Ward N, Dukkipati VSR, Johnson C, et al.
Comparison of electroencephalographic changes in response to acute electrical and
thermal stimuli with the tail immersion and hot plate test in rats administered with
opiorphin. BMC Neurol 2018;18:43.
33. Chen YF, Ching C, Wu TS, Wu CR, Hsieh WT, Tsai HY. Balanophora spicata and
lupeol acetate possess antinociceptive and anti-inflammatory activities in vivo and in
vitro. Evid-Based Compl Altern Med 2012;2012:371273.
34. Cavasotto CN, Phatak SS. Homology modeling in drug discovery: current trends and
applications. Drug Discov Today 2009;14:676-83.
Balkan Med J, Vol. 37, No.4, 2020
Jaffal et al. Antinociceptive Action of Moringa peregrina 195
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Homology modelling has matured into an important technique in structural biology, significantly contributing to narrowing the gap between known protein sequences and experimentally determined structures. Fully automated workflows and servers simplify and streamline the homology modelling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modelling results, their visualization and interpretation. Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modelling 25 years ago and been continuously further developed. Recently, its functionality has been extended to the modelling of homo- and heteromeric complexes. Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homology modelling. Other major improvements include the implementation of a new modelling engine, ProMod3 and the introduction a new local model quality estimation method, QMEANDisCo. SWISS-MODEL is freely available at https://swissmodel.expasy.org.
Article
Full-text available
Moringa is a sole genus of Moringaceae family with 13 species distributed in the tropical and subtropical regions. Among them, Moringa peregrina is one of the species which has wide range of traditional, nutritional, industrial, and medicinal values. The plant parts are used in folk medicine for many human health care purposes including diabetes, wound healing, disinfectant, fever, constipation, muscle pains, slimness, burns, labor pain, hypertension, malaria, stomach disorder, asthma, skin problems, and to expel a retained placenta. In addition to medicinal value, M. peregrina has cultural, spiritual, and religious connections with the native people of Arabian Peninsula. M. peregrina plant parts were tested for many pharmacological activities viz, antioxidant, anti-microbial, anti-diabetic, anti-spasmodic, hypertension, hepatotoxicity, lipid lowering activity, anti-inflammatory, anti-cancer, and memory disorders. Few active molecules belong to the class isothiocyanate, flavonoid, triterpenoid, phytosterol, polyphenol, and glycoside were also isolated, identified and reported for anti-microbial, anti-oxidant, anthelmintic, anti-mutagenic, neuroprotective, anti-cancer, anti-hypertensive, anti-diabetic, anti-infective, anti-allergic, anti-inflammatory, herbicidal, lipid lowering potential, anti-trypanosomal, and cytotoxic activities. So, the aim of the present review is to provide comprehensive information from recognized sources on the traditional uses, pharmacological efficacy and phytochemistry of the desert medicinal plant, M. peregrina. The information provided in this review will be very useful for further studies to develop novel therapeutic drugs.
Article
Full-text available
Background: The objective of this study was to compare the changes in the electroencephalogram (EEG) in response to noxious stimuli with tail flick and hot plate responses of rats administered opiorphin. Methods: Female Sprague -Dawley rats (n = 8 per group) randomly received intravenous (IV) injection of morphine (1 mg/kg,) or opiorphin (2 mg/kg,) or saline (0.5 ml,) in each of the three testing methods (EEG, tail flick and hot plate). Each type of test (n = 24 per test) was conducted in different population of rats on separate occasions. The tail flick and hot plate latencies were recorded until 5 min after test drug administration to conscious rats. The EEG was recorded in anaesthetised rats subjected to noxious thermal and electrical stimuli after test drug administration. At the end of 5 min in each of the testing methods rats were administered naloxone subcutaneously (SC) (1 mg/kg) and the test procedure was repeated. Results: There was no significant increase in the median frequency and spectral edge frequency (F50 & F95) of EEG, indicators of nociception, of morphine and opiorphin groups after noxious stimulation. Noxious stimuli caused a significant increase in both F50 and F95 of the saline group. An injection of naloxone significantly increased the F50, thus blocking the action of both opiorphin and morphine. There was a significant increase in the tail flick latency after administration of opiorphin and morphine as compared to the baseline values. Rats of morphine group spent significantly longer on the hot plate when compared to those of the opiorphin and saline groups. There was no significant difference in the hot plate latencies of opiorphin and saline groups. Conclusion: The results of this study suggest that the analgesic effect of opiorphin occurs at the spinal level and it is not as effective as morphine at supraspinal level. It may be due to rapid degradation of opiorphin or limited ability of opiorphin to cross the blood brain barrier or a higher dose of opiorphin is required for its action in the brain. Pharmacokinetic/pharmacodynamics studies along with in vivo penetration of opiorphin in the cerebrospinal fluid are required for further evaluation of opiorphin analgesia.
Article
Full-text available
This study was conducted to assess the in vivo and ex vivo immunomodulatory effect of the ethanol leaves extract of Moringa peregrina in Balb/c mice. For this study, five groups of 5 Balb/c mice were given a single acute subtoxic oral dose of the ethanolic extract at 1.13, 11.30, 23.40 and 113.4 mg/kg and the immunomodulatory effect was assessed on the 6 th day following the ingestion. In the (non-functional) assessment, the effect of the extract on the body weight, relative lymphoid organ weight, splenic cellularity and peripheral blood hematologic parameters were evaluated. While in the immunomod-ulation assessment (functional), we investigated the effect of the extract on the proliferative capacity of splenic lymphocytes and peripheral T and B lymphocytes using mitogen blastogenesis, mixed allogeneic MLR and IgM-Plaque forming cells assays. The ingestion of M. peregrina extract caused a significant increase in the body weight, weight and number of cells of spleen and lymph nodes of the treated mice. Furthermore, the count of RBCs, WBCs, platelets, hemoglobin concentration and PCV % were increased by the extract treatment in a dose-dependent manner. M. peregrina enhanced the proliferative responses of splenic lymphocytes for both T cell and B-cell mitogens. Likewise, the mixed lymphocyte reaction MLR assay has revealed a T-cell dependent proliferation enhancement in the extract treated mice. Moreover, the oral administration of M. peregrina leaves extracts significantly increased PFCs/10 6 splenocytes in a dose-dependent manner. In conclusion, subtoxic acute doses of M. peregrina extract demonstrated significant potential as an immunomodulatory agent even at the lowest dose of 1.13 mg/kg.
Article
Full-text available
Oxidative stress interferes with the functional roles of the hippocampus and results in cognitive decline. Antioxidant supplementation has a cognitive enhancing activity through protecting hippocampus brain cells from the damaging effects of the reactive oxygen species. The dried methanolic extract of the aboveground parts of Moringa peregrina (Forssk.) Fiori (Moringaceae) was hypothesized to have memory-enhancing activity via its antioxidative properties. HPLC and LC-MS methods were used for qualitative analysis of the marker compounds. Six major compounds of the methanolic extract of M. peregrina were identified, namely, rutin, myricetin, α-amyrin, β-amyrin, lupeol acetate, and β-sitosterol. Male Wistar rats were administered via oral gavage three dose levels (50, 100, and 500 mg/kg) of M. peregrina methanolic extract for 2 months. The radial arm water maze (RAWM) was used to test spatial learning and memory. In addition, ELISA was used to analyze the levels of brain-derived neurotrophic factor (BDNF) and to assess the level of some oxidative stress markers. M. peregrina (150 mg/kg) resulted in short- and long-term memory enhancement (P < 0.05). Moreover, M. peregrina administration elevated BDNF levels in the hippocampus (P < 0.05) and caused favorable changes in oxidative stress biomarkers. In particular, an increase in glutathione (GSH), a decrease in oxidized glutathione (GSSG), and an increase in the antioxidant enzyme glutathione peroxidase (GPx) levels in the hippocampus were elicited after treatment with M. peregrina. Taken together, our data show that oral administration of M. peregrina enhances both short- and long-term memory functions via combating oxidative stress and increasing BDNF levels in the hippocampus. Consuming this safe plant may thus help promote spatial learning and improve memory.
Article
Full-text available
Plants are rich source of natural bioactive phytochemicals, since many of photochemical compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly. The use of drugs and dietary supplements derived from plants has accelerated in recent years to treatment of infectious diseases. While more of current pharmaceuticals are derived from plants. Traditional healers have long used plants to prevent or cure infectious conditions. This review attempts to summarize the current status of chemical and biological screening efforts, as well as in vivo studies of their effectiveness and toxicity of Moringa peregrina. It is a wild tree and contains large number of phyto-constituents. Scientifically; it possessed various pharmacologic effects, including hypoglycemic, analgesic, anti-inflammatory, hypo-lipidimic and antioxidant activities.
Article
Full-text available
Objectives: Moringa oleifera is a highly valued plant distributed in many countries of the tropic and subtropics. Moringa oleifera leaves are a potential source of phytochemical ingredients claimed to have analgesic property. Pain is an unpleasant sensation, which in many cases represents the only symptom for the diagnosis of several diseases. Therefore analgesic drugs lacking the side effect as alternative to nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates are in demand by the society. The present study is undertaken to evaluate the analgesic activity of Moringa oleifera using acetic acid induced writhing test and Eddy′s hot plate test. Materials and Methods: It is a randomized control study. The present study was done using two experimental models. The albino mice were divided into six groups, each group consisting of 6 mice. A total of 36 mice were used in each of the two experimental models. Group I: Control (normal saline given orally at 2 ml/kg body weight); Group II: Standard (diclofenac 10 mg/kg i.p/ morphine 1 mg/kg i.p); Group III, IV, V, VI (ethanolic extract of Moringa oleifera (EMO) 50, 100, 200, 400 mg/kg, respectively). The EMO leaves were administered at 50, 100, 200, 400 mg/kg doses orally 1 hour before the experiments. For peripheral analgesic effect, acetic acid induced writhing test was used. The central analgesic effect was screened using Eddy′s hot plate method. The standard drug used in acetic acid induced writhing test was diclofenac and in Eddy′s hot plate test was morphine. Results: The EMO leaf showed significant (P < 0.01) analgesic activity at 100, 200, 400 mg/kg in the acetic acid induced writhing test showing 32.21%, 59.71% and 78.61% inhibition of writhes, respectively in comparison with the control. In the Eddy′s hot plate test EMO at 400 mg/kg showed significant (P < 0.01) analgesic activity from 15 min to 90 min with a mean rank ranging from 28.92 to 26.00, second mean rank following morphine in comparison with control. In both the tests, EMO showed significant (P < 0.01) analgesic activity in a dose-dependent manner. Conclusion: The ethanolic leaf extract of Moringa oleifera exhibited analgesic activity in both models showing its both central and peripheral analgesic actions.
Article
Full-text available
Aim: The purpose of this study is to evaluate the effect of aqueous leaf extract of Moringa oleifera (Moringaceae) on plasma glucose level, total cholesterol level, triglycerides (TG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in male albino rats. Study Design: Experimental method was adopted. Place and Duration of Study: Adeleke University, Ede, Nigeria and University of Ibadan, Nigeria between September 2012 and January, 2013. Methodology: Twenty-four male albino rats of the Wistar strain weighing between 160 and 200 g were used for this study. These were randomly assigned into 3 groups of 8 animals per group as normal control, diabetic control and diabetic treated with extract of Moringa oleifera. Diabetes was induced by 100 mg/kg of alloxan monohydrate. The control and the diabetic groups received distilled water while the diabetic treated group was administered 400 mg/kg body weight of aqueous leaf extract of Moringa oleifera for 28 days. At the end of the experiment, plasma glucose level, cholesterol, Triglycerides (TG), High Density Lipoprotein (HDL) and Low Density Lipoprotein (LDL) were determined in all the experimental animals after 12 hours fast. Results: The result showed significant increases (P<0.05) in plasma cholesterol, TG and LDL level of the diabetic control group when compared with the normal control group while there were no significant differences in the Moringa oleifera -treated diabetic group and the normal control group. The HDL however was not different in all the three groups. Conclusion: Oral administration of aqueous leaf extract of Moringa oleifera may reduce the plasma lipid imbalances associated with diabetes mellitus.
Article
Abstract Ononis spinosa (spiny restharrow) is a perennial herb that belongs to the Fabaceae family. Among several uses, the aerial parts of O. spinosa are used in traditional medicine for toothache. In this study, analgesic activity of the methanolic extract of leaves was studied. In writhing test, the 300 mg/kg and 600 mg/kg doses of O. spinosa extract produced 90.1% and 94.5% inhibition of abdominal cramps, respectively compared to 23.6% inhibition produced by 30 mg/kg diclofenac sodium. O. spinosa methanolic extract reduced the time of licking in early and late phases of formalin test. The inhibitory effect of O. spinosa extract was more pronounced in late phase. The lowest dose tested (300 mg/kg) of O. spinosa extract produced 81.0% inhibition compared to 50.5% inhibition in 30 mg/kg diclofenac sodium in the late phase of formalin test. This effect was not abrogated by glibenclamide, naloxone or atropine indicating that the action of O. spinosa in formalin test is not mediated by ATP-sensitive K+ channel, opioid or muscarinic receptors. In tail-flick and hot-plate tests, O. spinosa increased the latency time at 30 min and 150 min. Naloxone antagonized the action of O. spinosa in both tests suggesting an interaction with opioid receptor as a possible mechanism of O. spinosa in thermal pain models at the spinal and supraspinal levels. Phytochemical screening indicated the presence of phenolics, saponins, flavonoids, and terpenoids. Alkaloids, sterols, and anthraquinone glycosides were absent. HPLC analysis confirmed the presence kaempferol, apigenin and myricetin in the extract.
Article
Moringa oleifera has long been used in large demand in folk medicine to treat pain. The present study was undertaken to examine the antinociceptive and anti-inflammatory spectrum of M. oleifera leaf extracts discriminating the constituents’ nature by using different kind of experimental models in rats. Pharmacological evaluation of a non-polar and/or polar extracts at several doses (30–300 mg/kg, p.o.) was explored through experimental nociception using formalin test, carrageenan-induced paw edema and arthritis with subcutaneous injection of collagen in rats. Basic morphology characterization was done by scanning electronic microscopy and laser scanning confocal microscopy. Not only polar (from 30 or 100 mg/kg, p.o.) but also non-polar extract produced significant inhibition of the nociceptive behavior with major efficacy in the inflammatory response in different assessed experimental models. This antinociceptive activity involved constituents of different nature and depended on the intensity of the induced painful stimulus. Phytochemical analysis showed the presence of kaempferol-3-glucoside in the polar extract and fatty acids like chlorogenic acid, among others, in the non-polar extract. Data obtained with M. oleifera leaf extracts give evidence of its potential for pain treatment.